A5039276059- Pregnancy and preeclampsia studies
- Maternal and fetal healthcare
- Hemodynamic Monitoring and Therapy
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiovascular Issues in Pregnancy
- Ultrasound in Clinical Applications
- Non-Invasive Vital Sign Monitoring
- Cardiac Structural Anomalies and Repair
- Blood transfusion and management
- Maternal and Perinatal Health Interventions
- Appendicitis Diagnosis and Management
- Anesthesia and Pain Management
- Cardiac Arrhythmias and Treatments
- Blood Coagulation and Thrombosis Mechanisms
- Hemoglobinopathies and Related Disorders
- Renal and Vascular Pathologies
- Stuttering Research and Treatment
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Enhanced Recovery After Surgery
- Assisted Reproductive Technology and Twin Pregnancy
- Gestational Diabetes Research and Management
Hôpital Jeanne de Flandre
2015-2024
Centre Hospitalier Universitaire de Lille
2015-2023
The optimal dose of tranexamic acid to inhibit hyperfibrinolysis in postpartum haemorrhage is unclear. Tranexamic Acid Reduce Blood Loss Hemorrhagic Cesarean Delivery (TRACES) was a double-blind, placebo-controlled, randomised, multicentre dose-ranging study determine the dose-effect relationship for two regimens intravenous vs placebo.Women experiencing during Caesarean delivery were randomised receive placebo (n=60), 0.5 g (n=57), or 1 i.v. (n=58). Biomarkers fibrinolytic activation...
( Can J Anesth 2022;69:1340–1348) Hemodynamic variation is a well-known part of pregnancy, particularly in cardiac output (CO). CO reduction the third trimester prominent when patient supine position and weight pregnancy results compression inferior vena cava (IVC). This often corrected by simple shift to left lateral decubitus (LLD). Decreases can have severe consequences for mother child, circumstances postpartum hemorrhage. Therefore, accurate consistent monitoring important ensuring best...